NICOLETTE MCCRARY: Open Payments
NPI 1912670274 · LEXINGTON PARK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 37 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $769
Food & beverage: $669Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $228 |
| GENZYME CORPORATION | 5 | $127 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| UCB, Inc. | 4 | $91 |
| ABBVIE INC. | 5 | $86 |
| Amgen Inc. | 2 | $48 |
| Organon LLC | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $26 |
Products named: TREMFYA, DUPIXENT, COSENTYX, Bimzelx, SKYRIZI, OTEZLA, Oxistat, TALTZ.
Industry payments across MD — which companies pay providers there.
